TEBENTAFUSP-TEBN: 350 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
350
Total FAERS Reports
45 (12.9%)
Deaths Reported
112
Hospitalizations
350
As Primary/Secondary Suspect
14
Life-Threatening
Prescription
Status
FDA Application: 761228 ·
First Report: 20210101 · Latest Report: 20250902
What Are the Most Common TEBENTAFUSP-TEBN Side Effects?
#1 Most Reported
Pyrexia
63 reports (18.0%)
#2 Most Reported
Cytokine release syndrome
59 reports (16.9%)
#3 Most Reported
Hypotension
47 reports (13.4%)
All TEBENTAFUSP-TEBN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Pyrexia | 63 | 18.0% | 7 | 32 |
| Cytokine release syndrome | 59 | 16.9% | 11 | 26 |
| Hypotension | 47 | 13.4% | 7 | 33 |
| Rash | 43 | 12.3% | 2 | 21 |
| Disease progression | 42 | 12.0% | 9 | 6 |
| Chills | 38 | 10.9% | 4 | 21 |
| Product dose omission issue | 37 | 10.6% | 0 | 11 |
| Malignant neoplasm progression | 32 | 9.1% | 3 | 4 |
| Nausea | 29 | 8.3% | 2 | 12 |
| Vomiting | 22 | 6.3% | 1 | 13 |
| Pruritus | 21 | 6.0% | 0 | 14 |
| Death | 17 | 4.9% | 17 | 4 |
| Fatigue | 15 | 4.3% | 1 | 6 |
| Asthenia | 12 | 3.4% | 4 | 9 |
| Hypoxia | 12 | 3.4% | 3 | 7 |
| Tachycardia | 12 | 3.4% | 6 | 8 |
| Headache | 10 | 2.9% | 1 | 4 |
| Oxygen saturation decreased | 10 | 2.9% | 1 | 7 |
| Blood pressure decreased | 9 | 2.6% | 0 | 7 |
| Diarrhoea | 9 | 2.6% | 0 | 8 |
Who Reports TEBENTAFUSP-TEBN Side Effects? Age & Gender Data
Gender: 53.0% female, 47.0% male. Average age: 68.3 years. Most reports from: US. View detailed demographics →
Is TEBENTAFUSP-TEBN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2021 | 3 | 0 | 2 |
| 2022 | 51 | 6 | 20 |
| 2023 | 32 | 3 | 14 |
| 2024 | 69 | 11 | 32 |
| 2025 | 40 | 1 | 25 |
What Is TEBENTAFUSP-TEBN Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 127 |
| Metastatic ocular melanoma | 114 |
| Uveal melanoma | 72 |
| Choroid melanoma | 10 |
| Metastatic malignant melanoma | 7 |
TEBENTAFUSP-TEBN vs Alternatives: Which Is Safer?
TEBENTAFUSP-TEBN vs TECFIDERA
TEBENTAFUSP-TEBN vs TECHNETIUM TC-99M
TEBENTAFUSP-TEBN vs TECHNETIUM TC-99M MEDRONATE
TEBENTAFUSP-TEBN vs TECHNETIUM TC-99M OXIDRONATE
TEBENTAFUSP-TEBN vs TECHNETIUM TC-99M PERTECHNETATE
TEBENTAFUSP-TEBN vs TECHNETIUM TC-99M SESTAMIBI
TEBENTAFUSP-TEBN vs TECHNETIUM TC-99M TETROFOSMIN
TEBENTAFUSP-TEBN vs TECLISTAMAB
TEBENTAFUSP-TEBN vs TECLISTAMAB-CQYV
TEBENTAFUSP-TEBN vs TEDIZOLID
Official FDA Label for TEBENTAFUSP-TEBN
Official prescribing information from the FDA-approved drug label.